chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Culture wound negative, Decreased appetite, Dyspnoea, Haematocrit decreased, Headache
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 350022. A 34 year old male patient received a percutaneous injection in the left deltoid of SMALLPOX vaccine, (ACAM2000, lot number VV04003A) on 29 April 2009. The patient received the following vaccines 6 days earlier on 23 April 2009: dose 1 of ANTHRAX, dose 1 on HEP B, INFLUENZA (intramuscular) and TYPHOID. The manufacturer, lot number and site of administration were not reported. The patient was admitted to the hospital on 13 May 2009 with presumptive disseminated vaccinia and right knee cellulitis. Approximately 12 days after receiving SMALLPOX, the patient developed fever, chills, malaise, loss of appetite, headache, sore throat, productive cough and mild shortness of breath. The patient was initially seen on Day 12 (11 May 2009) for upper respiratory illness (URI) - type symptoms. The patient reported a 3 week history of intermittent chest congestion. He was diagnosed with pharyngitis and prescribed Z-pack, ZYRTEC and MUCINEX-D. That night, the patient noted pain and swelling at the SMALLPOX vaccination site and an increase in temperature (not measured). He was seen in the Emergency Room and diagnosed with left arm cellulitis. The patient was prescribed SEPTRA and CLINDAMYCIN. The patient was seen at a medical center for follow-up on 12 May 2009. He had a fever of 101.7 Farenheit. He also had a small tender pustule in right axilla and right knee pain and swelling. By 13 May 2009, the patient developed scattered pustular lesions over the scalp, right hip, and left leg. He also had increased right knee pain and swelling. He was admitted to hospital with a presumptive diagnoses of right knee cellulitis and disseminated vaccinia. An initial assessment by Infectious Disease performed on 14 May 2009 indicated: overall clinical improvement, but continued right knee swelling and warmth without tenderness; blanchable red rash at smallpox vaccine injection site (stable pustule), and over right knee; multiple scattered tense blisters, not excluding palms and soles: vesicles in various stages, characterized as yellow on erythematous base, umbilicated or ruptured, some becoming pustular, some with honey-colored crusts; distributed over scalp, neck, shoulders axillae, upper extremities, trunk, buttocks, lower extremities. Laboratory tests performed between 13 May 2009 and 15 May 2009 include: ESR 66-75 (high); CRP 10-12 (high); WBC 3000 range (low); Hematocrit 31-32 (low); Platelet 65-74 (low); normal chemistries, liver panel, LDH, ferritin, retic count, coagulation tests, and urinalysis; negative wound, blood and urine cultures. The patient recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Injection site erythema, Injection site pain, Injection site rash, Injection site reaction, Injection site swelling
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 350022. A 34 year old male patient received a percutaneous injection in the left deltoid of SMALLPOX vaccine, (ACAM2000, lot number VV04003A) on 29 April 2009. The patient received the following vaccines 6 days earlier on 23 April 2009: dose 1 of ANTHRAX, dose 1 on HEP B, INFLUENZA (intramuscular) and TYPHOID. The manufacturer, lot number and site of administration were not reported. The patient was admitted to the hospital on 13 May 2009 with presumptive disseminated vaccinia and right knee cellulitis. Approximately 12 days after receiving SMALLPOX, the patient developed fever, chills, malaise, loss of appetite, headache, sore throat, productive cough and mild shortness of breath. The patient was initially seen on Day 12 (11 May 2009) for upper respiratory illness (URI) - type symptoms. The patient reported a 3 week history of intermittent chest congestion. He was diagnosed with pharyngitis and prescribed Z-pack, ZYRTEC and MUCINEX-D. That night, the patient noted pain and swelling at the SMALLPOX vaccination site and an increase in temperature (not measured). He was seen in the Emergency Room and diagnosed with left arm cellulitis. The patient was prescribed SEPTRA and CLINDAMYCIN. The patient was seen at a medical center for follow-up on 12 May 2009. He had a fever of 101.7 Farenheit. He also had a small tender pustule in right axilla and right knee pain and swelling. By 13 May 2009, the patient developed scattered pustular lesions over the scalp, right hip, and left leg. He also had increased right knee pain and swelling. He was admitted to hospital with a presumptive diagnoses of right knee cellulitis and disseminated vaccinia. An initial assessment by Infectious Disease performed on 14 May 2009 indicated: overall clinical improvement, but continued right knee swelling and warmth without tenderness; blanchable red rash at smallpox vaccine injection site (stable pustule), and over right knee; multiple scattered tense blisters, not excluding palms and soles: vesicles in various stages, characterized as yellow on erythematous base, umbilicated or ruptured, some becoming pustular, some with honey-colored crusts; distributed over scalp, neck, shoulders axillae, upper extremities, trunk, buttocks, lower extremities. Laboratory tests performed between 13 May 2009 and 15 May 2009 include: ESR 66-75 (high); CRP 10-12 (high); WBC 3000 range (low); Hematocrit 31-32 (low); Platelet 65-74 (low); normal chemistries, liver panel, LDH, ferritin, retic count, coagulation tests, and urinalysis; negative wound, blood and urine cultures. The patient recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Joint swelling, Laboratory test normal, Liver function test, Malaise, Oropharyngeal pain
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 350022. A 34 year old male patient received a percutaneous injection in the left deltoid of SMALLPOX vaccine, (ACAM2000, lot number VV04003A) on 29 April 2009. The patient received the following vaccines 6 days earlier on 23 April 2009: dose 1 of ANTHRAX, dose 1 on HEP B, INFLUENZA (intramuscular) and TYPHOID. The manufacturer, lot number and site of administration were not reported. The patient was admitted to the hospital on 13 May 2009 with presumptive disseminated vaccinia and right knee cellulitis. Approximately 12 days after receiving SMALLPOX, the patient developed fever, chills, malaise, loss of appetite, headache, sore throat, productive cough and mild shortness of breath. The patient was initially seen on Day 12 (11 May 2009) for upper respiratory illness (URI) - type symptoms. The patient reported a 3 week history of intermittent chest congestion. He was diagnosed with pharyngitis and prescribed Z-pack, ZYRTEC and MUCINEX-D. That night, the patient noted pain and swelling at the SMALLPOX vaccination site and an increase in temperature (not measured). He was seen in the Emergency Room and diagnosed with left arm cellulitis. The patient was prescribed SEPTRA and CLINDAMYCIN. The patient was seen at a medical center for follow-up on 12 May 2009. He had a fever of 101.7 Farenheit. He also had a small tender pustule in right axilla and right knee pain and swelling. By 13 May 2009, the patient developed scattered pustular lesions over the scalp, right hip, and left leg. He also had increased right knee pain and swelling. He was admitted to hospital with a presumptive diagnoses of right knee cellulitis and disseminated vaccinia. An initial assessment by Infectious Disease performed on 14 May 2009 indicated: overall clinical improvement, but continued right knee swelling and warmth without tenderness; blanchable red rash at smallpox vaccine injection site (stable pustule), and over right knee; multiple scattered tense blisters, not excluding palms and soles: vesicles in various stages, characterized as yellow on erythematous base, umbilicated or ruptured, some becoming pustular, some with honey-colored crusts; distributed over scalp, neck, shoulders axillae, upper extremities, trunk, buttocks, lower extremities. Laboratory tests performed between 13 May 2009 and 15 May 2009 include: ESR 66-75 (high); CRP 10-12 (high); WBC 3000 range (low); Hematocrit 31-32 (low); Platelet 65-74 (low); normal chemistries, liver panel, LDH, ferritin, retic count, coagulation tests, and urinalysis; negative wound, blood and urine cultures. The patient recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pallor, Pharyngitis, Platelet count decreased, Productive cough, Progressive vaccinia
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 350022. A 34 year old male patient received a percutaneous injection in the left deltoid of SMALLPOX vaccine, (ACAM2000, lot number VV04003A) on 29 April 2009. The patient received the following vaccines 6 days earlier on 23 April 2009: dose 1 of ANTHRAX, dose 1 on HEP B, INFLUENZA (intramuscular) and TYPHOID. The manufacturer, lot number and site of administration were not reported. The patient was admitted to the hospital on 13 May 2009 with presumptive disseminated vaccinia and right knee cellulitis. Approximately 12 days after receiving SMALLPOX, the patient developed fever, chills, malaise, loss of appetite, headache, sore throat, productive cough and mild shortness of breath. The patient was initially seen on Day 12 (11 May 2009) for upper respiratory illness (URI) - type symptoms. The patient reported a 3 week history of intermittent chest congestion. He was diagnosed with pharyngitis and prescribed Z-pack, ZYRTEC and MUCINEX-D. That night, the patient noted pain and swelling at the SMALLPOX vaccination site and an increase in temperature (not measured). He was seen in the Emergency Room and diagnosed with left arm cellulitis. The patient was prescribed SEPTRA and CLINDAMYCIN. The patient was seen at a medical center for follow-up on 12 May 2009. He had a fever of 101.7 Farenheit. He also had a small tender pustule in right axilla and right knee pain and swelling. By 13 May 2009, the patient developed scattered pustular lesions over the scalp, right hip, and left leg. He also had increased right knee pain and swelling. He was admitted to hospital with a presumptive diagnoses of right knee cellulitis and disseminated vaccinia. An initial assessment by Infectious Disease performed on 14 May 2009 indicated: overall clinical improvement, but continued right knee swelling and warmth without tenderness; blanchable red rash at smallpox vaccine injection site (stable pustule), and over right knee; multiple scattered tense blisters, not excluding palms and soles: vesicles in various stages, characterized as yellow on erythematous base, umbilicated or ruptured, some becoming pustular, some with honey-colored crusts; distributed over scalp, neck, shoulders axillae, upper extremities, trunk, buttocks, lower extremities. Laboratory tests performed between 13 May 2009 and 15 May 2009 include: ESR 66-75 (high); CRP 10-12 (high); WBC 3000 range (low); Hematocrit 31-32 (low); Platelet 65-74 (low); normal chemistries, liver panel, LDH, ferritin, retic count, coagulation tests, and urinalysis; negative wound, blood and urine cultures. The patient recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pyrexia, Rash erythematous, Rash pustular, Red blood cell sedimentation rate increased, Reticulocyte count normal
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 350022. A 34 year old male patient received a percutaneous injection in the left deltoid of SMALLPOX vaccine, (ACAM2000, lot number VV04003A) on 29 April 2009. The patient received the following vaccines 6 days earlier on 23 April 2009: dose 1 of ANTHRAX, dose 1 on HEP B, INFLUENZA (intramuscular) and TYPHOID. The manufacturer, lot number and site of administration were not reported. The patient was admitted to the hospital on 13 May 2009 with presumptive disseminated vaccinia and right knee cellulitis. Approximately 12 days after receiving SMALLPOX, the patient developed fever, chills, malaise, loss of appetite, headache, sore throat, productive cough and mild shortness of breath. The patient was initially seen on Day 12 (11 May 2009) for upper respiratory illness (URI) - type symptoms. The patient reported a 3 week history of intermittent chest congestion. He was diagnosed with pharyngitis and prescribed Z-pack, ZYRTEC and MUCINEX-D. That night, the patient noted pain and swelling at the SMALLPOX vaccination site and an increase in temperature (not measured). He was seen in the Emergency Room and diagnosed with left arm cellulitis. The patient was prescribed SEPTRA and CLINDAMYCIN. The patient was seen at a medical center for follow-up on 12 May 2009. He had a fever of 101.7 Farenheit. He also had a small tender pustule in right axilla and right knee pain and swelling. By 13 May 2009, the patient developed scattered pustular lesions over the scalp, right hip, and left leg. He also had increased right knee pain and swelling. He was admitted to hospital with a presumptive diagnoses of right knee cellulitis and disseminated vaccinia. An initial assessment by Infectious Disease performed on 14 May 2009 indicated: overall clinical improvement, but continued right knee swelling and warmth without tenderness; blanchable red rash at smallpox vaccine injection site (stable pustule), and over right knee; multiple scattered tense blisters, not excluding palms and soles: vesicles in various stages, characterized as yellow on erythematous base, umbilicated or ruptured, some becoming pustular, some with honey-colored crusts; distributed over scalp, neck, shoulders axillae, upper extremities, trunk, buttocks, lower extremities. Laboratory tests performed between 13 May 2009 and 15 May 2009 include: ESR 66-75 (high); CRP 10-12 (high); WBC 3000 range (low); Hematocrit 31-32 (low); Platelet 65-74 (low); normal chemistries, liver panel, LDH, ferritin, retic count, coagulation tests, and urinalysis; negative wound, blood and urine cultures. The patient recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Serum ferritin normal, Skin warm, Upper respiratory tract congestion, Upper respiratory tract infection, Urine analysis normal
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 350022. A 34 year old male patient received a percutaneous injection in the left deltoid of SMALLPOX vaccine, (ACAM2000, lot number VV04003A) on 29 April 2009. The patient received the following vaccines 6 days earlier on 23 April 2009: dose 1 of ANTHRAX, dose 1 on HEP B, INFLUENZA (intramuscular) and TYPHOID. The manufacturer, lot number and site of administration were not reported. The patient was admitted to the hospital on 13 May 2009 with presumptive disseminated vaccinia and right knee cellulitis. Approximately 12 days after receiving SMALLPOX, the patient developed fever, chills, malaise, loss of appetite, headache, sore throat, productive cough and mild shortness of breath. The patient was initially seen on Day 12 (11 May 2009) for upper respiratory illness (URI) - type symptoms. The patient reported a 3 week history of intermittent chest congestion. He was diagnosed with pharyngitis and prescribed Z-pack, ZYRTEC and MUCINEX-D. That night, the patient noted pain and swelling at the SMALLPOX vaccination site and an increase in temperature (not measured). He was seen in the Emergency Room and diagnosed with left arm cellulitis. The patient was prescribed SEPTRA and CLINDAMYCIN. The patient was seen at a medical center for follow-up on 12 May 2009. He had a fever of 101.7 Farenheit. He also had a small tender pustule in right axilla and right knee pain and swelling. By 13 May 2009, the patient developed scattered pustular lesions over the scalp, right hip, and left leg. He also had increased right knee pain and swelling. He was admitted to hospital with a presumptive diagnoses of right knee cellulitis and disseminated vaccinia. An initial assessment by Infectious Disease performed on 14 May 2009 indicated: overall clinical improvement, but continued right knee swelling and warmth without tenderness; blanchable red rash at smallpox vaccine injection site (stable pustule), and over right knee; multiple scattered tense blisters, not excluding palms and soles: vesicles in various stages, characterized as yellow on erythematous base, umbilicated or ruptured, some becoming pustular, some with honey-colored crusts; distributed over scalp, neck, shoulders axillae, upper extremities, trunk, buttocks, lower extremities. Laboratory tests performed between 13 May 2009 and 15 May 2009 include: ESR 66-75 (high); CRP 10-12 (high); WBC 3000 range (low); Hematocrit 31-32 (low); Platelet 65-74 (low); normal chemistries, liver panel, LDH, ferritin, retic count, coagulation tests, and urinalysis; negative wound, blood and urine cultures. The patient recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: White blood cell count decreased
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 350022. A 34 year old male patient received a percutaneous injection in the left deltoid of SMALLPOX vaccine, (ACAM2000, lot number VV04003A) on 29 April 2009. The patient received the following vaccines 6 days earlier on 23 April 2009: dose 1 of ANTHRAX, dose 1 on HEP B, INFLUENZA (intramuscular) and TYPHOID. The manufacturer, lot number and site of administration were not reported. The patient was admitted to the hospital on 13 May 2009 with presumptive disseminated vaccinia and right knee cellulitis. Approximately 12 days after receiving SMALLPOX, the patient developed fever, chills, malaise, loss of appetite, headache, sore throat, productive cough and mild shortness of breath. The patient was initially seen on Day 12 (11 May 2009) for upper respiratory illness (URI) - type symptoms. The patient reported a 3 week history of intermittent chest congestion. He was diagnosed with pharyngitis and prescribed Z-pack, ZYRTEC and MUCINEX-D. That night, the patient noted pain and swelling at the SMALLPOX vaccination site and an increase in temperature (not measured). He was seen in the Emergency Room and diagnosed with left arm cellulitis. The patient was prescribed SEPTRA and CLINDAMYCIN. The patient was seen at a medical center for follow-up on 12 May 2009. He had a fever of 101.7 Farenheit. He also had a small tender pustule in right axilla and right knee pain and swelling. By 13 May 2009, the patient developed scattered pustular lesions over the scalp, right hip, and left leg. He also had increased right knee pain and swelling. He was admitted to hospital with a presumptive diagnoses of right knee cellulitis and disseminated vaccinia. An initial assessment by Infectious Disease performed on 14 May 2009 indicated: overall clinical improvement, but continued right knee swelling and warmth without tenderness; blanchable red rash at smallpox vaccine injection site (stable pustule), and over right knee; multiple scattered tense blisters, not excluding palms and soles: vesicles in various stages, characterized as yellow on erythematous base, umbilicated or ruptured, some becoming pustular, some with honey-colored crusts; distributed over scalp, neck, shoulders axillae, upper extremities, trunk, buttocks, lower extremities. Laboratory tests performed between 13 May 2009 and 15 May 2009 include: ESR 66-75 (high); CRP 10-12 (high); WBC 3000 range (low); Hematocrit 31-32 (low); Platelet 65-74 (low); normal chemistries, liver panel, LDH, ferritin, retic count, coagulation tests, and urinalysis; negative wound, blood and urine cultures. The patient recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Arthralgia, Biopsy skin abnormal, Blister, Blood culture negative, Blood lactate dehydrogenase normal
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 350022. A 34 year old male patient received a percutaneous injection in the left deltoid of SMALLPOX vaccine, (ACAM2000, lot number VV04003A) on 29 April 2009. The patient received the following vaccines 6 days earlier on 23 April 2009: dose 1 of ANTHRAX, dose 1 on HEP B, INFLUENZA (intramuscular) and TYPHOID. The manufacturer, lot number and site of administration were not reported. The patient was admitted to the hospital on 13 May 2009 with presumptive disseminated vaccinia and right knee cellulitis. Approximately 12 days after receiving SMALLPOX, the patient developed fever, chills, malaise, loss of appetite, headache, sore throat, productive cough and mild shortness of breath. The patient was initially seen on Day 12 (11 May 2009) for upper respiratory illness (URI) - type symptoms. The patient reported a 3 week history of intermittent chest congestion. He was diagnosed with pharyngitis and prescribed Z-pack, ZYRTEC and MUCINEX-D. That night, the patient noted pain and swelling at the SMALLPOX vaccination site and an increase in temperature (not measured). He was seen in the Emergency Room and diagnosed with left arm cellulitis. The patient was prescribed SEPTRA and CLINDAMYCIN. The patient was seen at a medical center for follow-up on 12 May 2009. He had a fever of 101.7 Farenheit. He also had a small tender pustule in right axilla and right knee pain and swelling. By 13 May 2009, the patient developed scattered pustular lesions over the scalp, right hip, and left leg. He also had increased right knee pain and swelling. He was admitted to hospital with a presumptive diagnoses of right knee cellulitis and disseminated vaccinia. An initial assessment by Infectious Disease performed on 14 May 2009 indicated: overall clinical improvement, but continued right knee swelling and warmth without tenderness; blanchable red rash at smallpox vaccine injection site (stable pustule), and over right knee; multiple scattered tense blisters, not excluding palms and soles: vesicles in various stages, characterized as yellow on erythematous base, umbilicated or ruptured, some becoming pustular, some with honey-colored crusts; distributed over scalp, neck, shoulders axillae, upper extremities, trunk, buttocks, lower extremities. Laboratory tests performed between 13 May 2009 and 15 May 2009 include: ESR 66-75 (high); CRP 10-12 (high); WBC 3000 range (low); Hematocrit 31-32 (low); Platelet 65-74 (low); normal chemistries, liver panel, LDH, ferritin, retic count, coagulation tests, and urinalysis; negative wound, blood and urine cultures. The patient recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Bone marrow failure, C-reactive protein increased, Cellulitis, Chills, Coagulation test normal
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 350022. A 34 year old male patient received a percutaneous injection in the left deltoid of SMALLPOX vaccine, (ACAM2000, lot number VV04003A) on 29 April 2009. The patient received the following vaccines 6 days earlier on 23 April 2009: dose 1 of ANTHRAX, dose 1 on HEP B, INFLUENZA (intramuscular) and TYPHOID. The manufacturer, lot number and site of administration were not reported. The patient was admitted to the hospital on 13 May 2009 with presumptive disseminated vaccinia and right knee cellulitis. Approximately 12 days after receiving SMALLPOX, the patient developed fever, chills, malaise, loss of appetite, headache, sore throat, productive cough and mild shortness of breath. The patient was initially seen on Day 12 (11 May 2009) for upper respiratory illness (URI) - type symptoms. The patient reported a 3 week history of intermittent chest congestion. He was diagnosed with pharyngitis and prescribed Z-pack, ZYRTEC and MUCINEX-D. That night, the patient noted pain and swelling at the SMALLPOX vaccination site and an increase in temperature (not measured). He was seen in the Emergency Room and diagnosed with left arm cellulitis. The patient was prescribed SEPTRA and CLINDAMYCIN. The patient was seen at a medical center for follow-up on 12 May 2009. He had a fever of 101.7 Farenheit. He also had a small tender pustule in right axilla and right knee pain and swelling. By 13 May 2009, the patient developed scattered pustular lesions over the scalp, right hip, and left leg. He also had increased right knee pain and swelling. He was admitted to hospital with a presumptive diagnoses of right knee cellulitis and disseminated vaccinia. An initial assessment by Infectious Disease performed on 14 May 2009 indicated: overall clinical improvement, but continued right knee swelling and warmth without tenderness; blanchable red rash at smallpox vaccine injection site (stable pustule), and over right knee; multiple scattered tense blisters, not excluding palms and soles: vesicles in various stages, characterized as yellow on erythematous base, umbilicated or ruptured, some becoming pustular, some with honey-colored crusts; distributed over scalp, neck, shoulders axillae, upper extremities, trunk, buttocks, lower extremities. Laboratory tests performed between 13 May 2009 and 15 May 2009 include: ESR 66-75 (high); CRP 10-12 (high); WBC 3000 range (low); Hematocrit 31-32 (low); Platelet 65-74 (low); normal chemistries, liver panel, LDH, ferritin, retic count, coagulation tests, and urinalysis; negative wound, blood and urine cultures. The patient recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Culture urine negative, Culture wound negative, Decreased appetite, Dermatitis, Dizziness
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 350022. A 34 year old male patient received a percutaneous injection in the left deltoid of SMALLPOX vaccine, (ACAM2000, lot number VV04003A) on 29 April 2009. The patient received the following vaccines 6 days earlier on 23 April 2009: dose 1 of ANTHRAX, dose 1 on HEP B, INFLUENZA (intramuscular) and TYPHOID. The manufacturer, lot number and site of administration were not reported. The patient was admitted to the hospital on 13 May 2009 with presumptive disseminated vaccinia and right knee cellulitis. Approximately 12 days after receiving SMALLPOX, the patient developed fever, chills, malaise, loss of appetite, headache, sore throat, productive cough and mild shortness of breath. The patient was initially seen on Day 12 (11 May 2009) for upper respiratory illness (URI) - type symptoms. The patient reported a 3 week history of intermittent chest congestion. He was diagnosed with pharyngitis and prescribed Z-pack, ZYRTEC and MUCINEX-D. That night, the patient noted pain and swelling at the SMALLPOX vaccination site and an increase in temperature (not measured). He was seen in the Emergency Room and diagnosed with left arm cellulitis. The patient was prescribed SEPTRA and CLINDAMYCIN. The patient was seen at a medical center for follow-up on 12 May 2009. He had a fever of 101.7 Farenheit. He also had a small tender pustule in right axilla and right knee pain and swelling. By 13 May 2009, the patient developed scattered pustular lesions over the scalp, right hip, and left leg. He also had increased right knee pain and swelling. He was admitted to hospital with a presumptive diagnoses of right knee cellulitis and disseminated vaccinia. An initial assessment by Infectious Disease performed on 14 May 2009 indicated: overall clinical improvement, but continued right knee swelling and warmth without tenderness; blanchable red rash at smallpox vaccine injection site (stable pustule), and over right knee; multiple scattered tense blisters, not excluding palms and soles: vesicles in various stages, characterized as yellow on erythematous base, umbilicated or ruptured, some becoming pustular, some with honey-colored crusts; distributed over scalp, neck, shoulders axillae, upper extremities, trunk, buttocks, lower extremities. Laboratory tests performed between 13 May 2009 and 15 May 2009 include: ESR 66-75 (high); CRP 10-12 (high); WBC 3000 range (low); Hematocrit 31-32 (low); Platelet 65-74 (low); normal chemistries, liver panel, LDH, ferritin, retic count, coagulation tests, and urinalysis; negative wound, blood and urine cultures. The patient recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Dyspnoea, Epidermal necrosis, Erythema, Generalised vaccinia, Haematocrit decreased
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 350022. A 34 year old male patient received a percutaneous injection in the left deltoid of SMALLPOX vaccine, (ACAM2000, lot number VV04003A) on 29 April 2009. The patient received the following vaccines 6 days earlier on 23 April 2009: dose 1 of ANTHRAX, dose 1 on HEP B, INFLUENZA (intramuscular) and TYPHOID. The manufacturer, lot number and site of administration were not reported. The patient was admitted to the hospital on 13 May 2009 with presumptive disseminated vaccinia and right knee cellulitis. Approximately 12 days after receiving SMALLPOX, the patient developed fever, chills, malaise, loss of appetite, headache, sore throat, productive cough and mild shortness of breath. The patient was initially seen on Day 12 (11 May 2009) for upper respiratory illness (URI) - type symptoms. The patient reported a 3 week history of intermittent chest congestion. He was diagnosed with pharyngitis and prescribed Z-pack, ZYRTEC and MUCINEX-D. That night, the patient noted pain and swelling at the SMALLPOX vaccination site and an increase in temperature (not measured). He was seen in the Emergency Room and diagnosed with left arm cellulitis. The patient was prescribed SEPTRA and CLINDAMYCIN. The patient was seen at a medical center for follow-up on 12 May 2009. He had a fever of 101.7 Farenheit. He also had a small tender pustule in right axilla and right knee pain and swelling. By 13 May 2009, the patient developed scattered pustular lesions over the scalp, right hip, and left leg. He also had increased right knee pain and swelling. He was admitted to hospital with a presumptive diagnoses of right knee cellulitis and disseminated vaccinia. An initial assessment by Infectious Disease performed on 14 May 2009 indicated: overall clinical improvement, but continued right knee swelling and warmth without tenderness; blanchable red rash at smallpox vaccine injection site (stable pustule), and over right knee; multiple scattered tense blisters, not excluding palms and soles: vesicles in various stages, characterized as yellow on erythematous base, umbilicated or ruptured, some becoming pustular, some with honey-colored crusts; distributed over scalp, neck, shoulders axillae, upper extremities, trunk, buttocks, lower extremities. Laboratory tests performed between 13 May 2009 and 15 May 2009 include: ESR 66-75 (high); CRP 10-12 (high); WBC 3000 range (low); Hematocrit 31-32 (low); Platelet 65-74 (low); normal chemistries, liver panel, LDH, ferritin, retic count, coagulation tests, and urinalysis; negative wound, blood and urine cultures. The patient recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Headache, Induration, Inflammatory marker increased, Injection site erythema, Injection site rash
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 350022. A 34 year old male patient received a percutaneous injection in the left deltoid of SMALLPOX vaccine, (ACAM2000, lot number VV04003A) on 29 April 2009. The patient received the following vaccines 6 days earlier on 23 April 2009: dose 1 of ANTHRAX, dose 1 on HEP B, INFLUENZA (intramuscular) and TYPHOID. The manufacturer, lot number and site of administration were not reported. The patient was admitted to the hospital on 13 May 2009 with presumptive disseminated vaccinia and right knee cellulitis. Approximately 12 days after receiving SMALLPOX, the patient developed fever, chills, malaise, loss of appetite, headache, sore throat, productive cough and mild shortness of breath. The patient was initially seen on Day 12 (11 May 2009) for upper respiratory illness (URI) - type symptoms. The patient reported a 3 week history of intermittent chest congestion. He was diagnosed with pharyngitis and prescribed Z-pack, ZYRTEC and MUCINEX-D. That night, the patient noted pain and swelling at the SMALLPOX vaccination site and an increase in temperature (not measured). He was seen in the Emergency Room and diagnosed with left arm cellulitis. The patient was prescribed SEPTRA and CLINDAMYCIN. The patient was seen at a medical center for follow-up on 12 May 2009. He had a fever of 101.7 Farenheit. He also had a small tender pustule in right axilla and right knee pain and swelling. By 13 May 2009, the patient developed scattered pustular lesions over the scalp, right hip, and left leg. He also had increased right knee pain and swelling. He was admitted to hospital with a presumptive diagnoses of right knee cellulitis and disseminated vaccinia. An initial assessment by Infectious Disease performed on 14 May 2009 indicated: overall clinical improvement, but continued right knee swelling and warmth without tenderness; blanchable red rash at smallpox vaccine injection site (stable pustule), and over right knee; multiple scattered tense blisters, not excluding palms and soles: vesicles in various stages, characterized as yellow on erythematous base, umbilicated or ruptured, some becoming pustular, some with honey-colored crusts; distributed over scalp, neck, shoulders axillae, upper extremities, trunk, buttocks, lower extremities. Laboratory tests performed between 13 May 2009 and 15 May 2009 include: ESR 66-75 (high); CRP 10-12 (high); WBC 3000 range (low); Hematocrit 31-32 (low); Platelet 65-74 (low); normal chemistries, liver panel, LDH, ferritin, retic count, coagulation tests, and urinalysis; negative wound, blood and urine cultures. The patient recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Intensive care, Joint swelling, Joint warmth, Laboratory test normal, Liver function test normal
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 350022. A 34 year old male patient received a percutaneous injection in the left deltoid of SMALLPOX vaccine, (ACAM2000, lot number VV04003A) on 29 April 2009. The patient received the following vaccines 6 days earlier on 23 April 2009: dose 1 of ANTHRAX, dose 1 on HEP B, INFLUENZA (intramuscular) and TYPHOID. The manufacturer, lot number and site of administration were not reported. The patient was admitted to the hospital on 13 May 2009 with presumptive disseminated vaccinia and right knee cellulitis. Approximately 12 days after receiving SMALLPOX, the patient developed fever, chills, malaise, loss of appetite, headache, sore throat, productive cough and mild shortness of breath. The patient was initially seen on Day 12 (11 May 2009) for upper respiratory illness (URI) - type symptoms. The patient reported a 3 week history of intermittent chest congestion. He was diagnosed with pharyngitis and prescribed Z-pack, ZYRTEC and MUCINEX-D. That night, the patient noted pain and swelling at the SMALLPOX vaccination site and an increase in temperature (not measured). He was seen in the Emergency Room and diagnosed with left arm cellulitis. The patient was prescribed SEPTRA and CLINDAMYCIN. The patient was seen at a medical center for follow-up on 12 May 2009. He had a fever of 101.7 Farenheit. He also had a small tender pustule in right axilla and right knee pain and swelling. By 13 May 2009, the patient developed scattered pustular lesions over the scalp, right hip, and left leg. He also had increased right knee pain and swelling. He was admitted to hospital with a presumptive diagnoses of right knee cellulitis and disseminated vaccinia. An initial assessment by Infectious Disease performed on 14 May 2009 indicated: overall clinical improvement, but continued right knee swelling and warmth without tenderness; blanchable red rash at smallpox vaccine injection site (stable pustule), and over right knee; multiple scattered tense blisters, not excluding palms and soles: vesicles in various stages, characterized as yellow on erythematous base, umbilicated or ruptured, some becoming pustular, some with honey-colored crusts; distributed over scalp, neck, shoulders axillae, upper extremities, trunk, buttocks, lower extremities. Laboratory tests performed between 13 May 2009 and 15 May 2009 include: ESR 66-75 (high); CRP 10-12 (high); WBC 3000 range (low); Hematocrit 31-32 (low); Platelet 65-74 (low); normal chemistries, liver panel, LDH, ferritin, retic count, coagulation tests, and urinalysis; negative wound, blood and urine cultures. The patient recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Malaise, Oropharyngeal pain, Pain, Pain of skin, Pallor
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 350022. A 34 year old male patient received a percutaneous injection in the left deltoid of SMALLPOX vaccine, (ACAM2000, lot number VV04003A) on 29 April 2009. The patient received the following vaccines 6 days earlier on 23 April 2009: dose 1 of ANTHRAX, dose 1 on HEP B, INFLUENZA (intramuscular) and TYPHOID. The manufacturer, lot number and site of administration were not reported. The patient was admitted to the hospital on 13 May 2009 with presumptive disseminated vaccinia and right knee cellulitis. Approximately 12 days after receiving SMALLPOX, the patient developed fever, chills, malaise, loss of appetite, headache, sore throat, productive cough and mild shortness of breath. The patient was initially seen on Day 12 (11 May 2009) for upper respiratory illness (URI) - type symptoms. The patient reported a 3 week history of intermittent chest congestion. He was diagnosed with pharyngitis and prescribed Z-pack, ZYRTEC and MUCINEX-D. That night, the patient noted pain and swelling at the SMALLPOX vaccination site and an increase in temperature (not measured). He was seen in the Emergency Room and diagnosed with left arm cellulitis. The patient was prescribed SEPTRA and CLINDAMYCIN. The patient was seen at a medical center for follow-up on 12 May 2009. He had a fever of 101.7 Farenheit. He also had a small tender pustule in right axilla and right knee pain and swelling. By 13 May 2009, the patient developed scattered pustular lesions over the scalp, right hip, and left leg. He also had increased right knee pain and swelling. He was admitted to hospital with a presumptive diagnoses of right knee cellulitis and disseminated vaccinia. An initial assessment by Infectious Disease performed on 14 May 2009 indicated: overall clinical improvement, but continued right knee swelling and warmth without tenderness; blanchable red rash at smallpox vaccine injection site (stable pustule), and over right knee; multiple scattered tense blisters, not excluding palms and soles: vesicles in various stages, characterized as yellow on erythematous base, umbilicated or ruptured, some becoming pustular, some with honey-colored crusts; distributed over scalp, neck, shoulders axillae, upper extremities, trunk, buttocks, lower extremities. Laboratory tests performed between 13 May 2009 and 15 May 2009 include: ESR 66-75 (high); CRP 10-12 (high); WBC 3000 range (low); Hematocrit 31-32 (low); Platelet 65-74 (low); normal chemistries, liver panel, LDH, ferritin, retic count, coagulation tests, and urinalysis; negative wound, blood and urine cultures. The patient recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pancytopenia, Pharyngitis, Platelet count decreased, Productive cough, Progressive vaccinia
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 350022. A 34 year old male patient received a percutaneous injection in the left deltoid of SMALLPOX vaccine, (ACAM2000, lot number VV04003A) on 29 April 2009. The patient received the following vaccines 6 days earlier on 23 April 2009: dose 1 of ANTHRAX, dose 1 on HEP B, INFLUENZA (intramuscular) and TYPHOID. The manufacturer, lot number and site of administration were not reported. The patient was admitted to the hospital on 13 May 2009 with presumptive disseminated vaccinia and right knee cellulitis. Approximately 12 days after receiving SMALLPOX, the patient developed fever, chills, malaise, loss of appetite, headache, sore throat, productive cough and mild shortness of breath. The patient was initially seen on Day 12 (11 May 2009) for upper respiratory illness (URI) - type symptoms. The patient reported a 3 week history of intermittent chest congestion. He was diagnosed with pharyngitis and prescribed Z-pack, ZYRTEC and MUCINEX-D. That night, the patient noted pain and swelling at the SMALLPOX vaccination site and an increase in temperature (not measured). He was seen in the Emergency Room and diagnosed with left arm cellulitis. The patient was prescribed SEPTRA and CLINDAMYCIN. The patient was seen at a medical center for follow-up on 12 May 2009. He had a fever of 101.7 Farenheit. He also had a small tender pustule in right axilla and right knee pain and swelling. By 13 May 2009, the patient developed scattered pustular lesions over the scalp, right hip, and left leg. He also had increased right knee pain and swelling. He was admitted to hospital with a presumptive diagnoses of right knee cellulitis and disseminated vaccinia. An initial assessment by Infectious Disease performed on 14 May 2009 indicated: overall clinical improvement, but continued right knee swelling and warmth without tenderness; blanchable red rash at smallpox vaccine injection site (stable pustule), and over right knee; multiple scattered tense blisters, not excluding palms and soles: vesicles in various stages, characterized as yellow on erythematous base, umbilicated or ruptured, some becoming pustular, some with honey-colored crusts; distributed over scalp, neck, shoulders axillae, upper extremities, trunk, buttocks, lower extremities. Laboratory tests performed between 13 May 2009 and 15 May 2009 include: ESR 66-75 (high); CRP 10-12 (high); WBC 3000 range (low); Hematocrit 31-32 (low); Platelet 65-74 (low); normal chemistries, liver panel, LDH, ferritin, retic count, coagulation tests, and urinalysis; negative wound, blood and urine cultures. The patient recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.